Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126221821 | 12622182 | 1 | I | 201604 | 20160517 | 20160804 | 20160804 | PER | US-ASTRAZENECA-2016SE54525 | ASTRAZENECA | 715.00 | MON | F | Y | 74.80000 | KG | 20160804 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126221821 | 12622182 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | N | U | 21153 | CAPSULE | ||||||||
| 126221821 | 12622182 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | GENERIC, 40 MG DAILY | N | U | 21153 | ||||||||
| 126221821 | 12622182 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | U | U | 0 | 25 | MG | QD | ||||||
| 126221821 | 12622182 | 4 | C | XANAX | ALPRAZOLAM | 1 | 1 MG AS REQUIRED | 0 | |||||||||||
| 126221821 | 12622182 | 5 | C | XANAX | ALPRAZOLAM | 1 | 1 MG AS REQUIRED | 0 | |||||||||||
| 126221821 | 12622182 | 6 | C | XANAX | ALPRAZOLAM | 1 | 1 MG AS REQUIRED | 0 | |||||||||||
| 126221821 | 12622182 | 7 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | 100 | MG | QD | |||||||||
| 126221821 | 12622182 | 8 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | 100 | MG | QD | |||||||||
| 126221821 | 12622182 | 9 | C | QUINAPRIL. | QUINAPRIL | 1 | 0 | 40 | MG | QD | |||||||||
| 126221821 | 12622182 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 126221821 | 12622182 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | ONCE A MONTH | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126221821 | 12622182 | 1 | Gastrooesophageal reflux disease |
| 126221821 | 12622182 | 2 | Gastrooesophageal reflux disease |
| 126221821 | 12622182 | 3 | Heart rate abnormal |
| 126221821 | 12622182 | 4 | Anxiety |
| 126221821 | 12622182 | 5 | Tinnitus |
| 126221821 | 12622182 | 6 | Ill-defined disorder |
| 126221821 | 12622182 | 7 | Generalised anxiety disorder |
| 126221821 | 12622182 | 8 | Tinnitus |
| 126221821 | 12622182 | 9 | Hypertension |
| 126221821 | 12622182 | 10 | Folate deficiency |
| 126221821 | 12622182 | 11 | Vitamin D deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126221821 | 12622182 | Abdominal distension | |
| 126221821 | 12622182 | Constipation | |
| 126221821 | 12622182 | Drug ineffective | |
| 126221821 | 12622182 | Dysgeusia | |
| 126221821 | 12622182 | Dyspepsia | |
| 126221821 | 12622182 | Eructation | |
| 126221821 | 12622182 | Gastrooesophageal reflux disease | |
| 126221821 | 12622182 | Haemorrhoids | |
| 126221821 | 12622182 | Intentional product misuse | |
| 126221821 | 12622182 | Malaise | |
| 126221821 | 12622182 | Oesophageal irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126221821 | 12622182 | 10 | 2015 | 0 |